HUMAN GENOME SCIENCES INC Net Income
HUMAN GENOME SCIENCES INC reported Net Income of -$92.80 million for the 3-month period ending 2012-06-30, per its 10-Q filed 2012-07-26.
Discontinued › Income Statement
us-gaap:NetIncomeLoss · last filed 2012-07-26
- HUMAN GENOME SCIENCES INC net income (loss) attributable to parent for the quarter ending 2012-06-30 was -$92.80M.
- HUMAN GENOME SCIENCES INC net income (loss) attributable to parent for the quarter ending 2012-03-31 was -$93.50M.
- HUMAN GENOME SCIENCES INC net income (loss) attributable to parent for the quarter ending 2011-12-31 was -$81.02M.
- HUMAN GENOME SCIENCES INC net income (loss) attributable to parent for the quarter ending 2011-09-30 was -$88.43M.
- HUMAN GENOME SCIENCES INC net income (loss) attributable to parent for fiscal 2011 was -$381.11M.
- HUMAN GENOME SCIENCES INC net income (loss) attributable to parent for fiscal 2010 was -$233.23M, a 4221.42% decline from fiscal 2009.
- HUMAN GENOME SCIENCES INC net income (loss) attributable to parent for fiscal 2009 was $5.66M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|
| 2012-06-30 | -$92.80M 10-Q · filed 2012-07-26 | -$186.30M 10-Q · filed 2012-07-26 | -$267.32M derived: sum of 3 quarters · filed 2012-07-26 | -$355.75M derived: sum of 4 quarters · filed 2012-07-26 |
| 2012-03-31 | -$93.50M 10-Q · filed 2012-04-26 | -$174.52M derived: sum of 2 quarters · filed 2012-04-26 | -$262.95M derived: sum of 3 quarters · filed 2012-04-26 | -$343.61M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-12-31 | -$81.02M 10-K · filed 2012-02-28 | -$169.45M derived: sum of 2 quarters · filed 2012-02-28 | -$250.11M derived: sum of 3 quarters · filed 2012-07-26 | -$381.11M 10-K · filed 2012-02-28 |
| 2011-09-30 | -$88.43M 10-K · filed 2012-02-28 | -$169.09M derived: sum of 2 quarters · filed 2012-07-26 | -$300.08M 10-Q · filed 2011-10-28 | -$387.72M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-06-30 | -$80.66M 10-Q · filed 2012-07-26 | -$211.66M 10-Q · filed 2012-07-26 | -$299.29M derived: sum of 3 quarters · filed 2012-07-26 | -$340.15M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-03-31 | -$131.00M 10-Q · filed 2012-04-26 | -$218.63M derived: sum of 2 quarters · filed 2012-04-26 | -$259.49M derived: sum of 3 quarters · filed 2012-04-26 | -$316.35M derived: sum of 4 quarters · filed 2012-04-26 |
| 2010-12-31 | -$87.63M 10-K · filed 2012-02-28 | -$128.49M derived: sum of 2 quarters · filed 2012-02-28 | -$185.35M derived: sum of 3 quarters · filed 2012-02-28 | -$233.23M 10-K · filed 2012-02-28 |
| 2010-09-30 | -$40.86M 10-K · filed 2012-02-28 | -$97.72M derived: sum of 2 quarters · filed 2012-02-28 | -$145.60M 10-Q · filed 2011-10-28 | |
| 2010-06-30 | -$56.86M 10-K · filed 2012-02-28 | -$104.74M 10-Q · filed 2011-07-28 | ||
| 2010-03-31 | -$47.88M 10-K · filed 2012-02-28 | |||
| 2009-12-31 | $5.66M 10-K · filed 2012-02-28 |